Corcept Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Corcept Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Corcept Therapeutics Inc
Rating: 1.8644445
Author: Trendlyne DVM scores

Momentum Trap

about

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The...

89.91 0.19 (0.21%)

213.71% Gain from 52W Low

563.8K

XNAS Volume

XNAS 17 Jul, 2026 3:23 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

27.5 / 100

Technically Moderately Bullish

66.1 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

106

1Yr Price target upside is 18%

3 analysts

Corcept Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Corcept Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The...

213.71% Gain from 52W Low

SWOT Analysis

Corcept Therapeutics Inc Live Price Chart

Corcept Therapeutics Inc Live Price Chart